eribulin mesylate,copanlisib
bayer,eisai pharmaceutical
['tnbc', 'eribulin', 'breast', 'copanlisib']
 get the initial results for #etctn (10382) #tnbc #breastcancer study at #asco22 tomorrow (6/6)! "testing the addition of copanlisib to eribulin for the treatment of advanced-stage triple negative breast cancer , led by dr. bagegni of . 
Official Twitter account of the NCI Cancer Therapy Evaluation Program, providing updates to our trials research community. Privacy: https://t.co/47s9FxzVVe.